Insights From the Pre-Immunotherapy Era
Patients with multiple myeloma (MM) remain exceptionally vulnerable to infections, which greatly increases mortality risk. Although the advent of novel treatments has brought many benefits to this patient population, individuals with multiple myeloma are 5 times more likely to contract infections, according to a recent population-based study published in Haematologica.1 Infection risk concept; floating viral … Read more